CompletedNot Applicable

Evaluating the Effectiveness of a Chronic Disease Management Program for Gout

United States104 participantsStarted 2012-01

Plain-language summary

The aim of this study is to test the effectiveness of a pharmacist-staffed, protocol-based chronic disease management program compared to patients receiving usual care in achieving a target serum uric acid level in patients with recurrent gout.

Who can participate

Age range21 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Three or more outpatient/ED visits in a 24-month period prior to selection for study with one of these primary visit diagnoses: * Gouty arthropathy * Gout, unspecified * Gout with other specified manifestations * Tophaceous gout of ear (274.81) or other sites * Gouty nephropathy At least 2 years of continuous Kaiser Foundation Hospital Plan membership Baseline uric acid level above 7.0mg/dl Exclusion Criteria: * Current cancer diagnosis with active treatment * End stage renal disease * Pregnant or lactating * Patients with a diagnosis of dementia * Terminally ill patients

What they're measuring

Serum Uric Acid Level

Timeframe: change from baseline at 6 months follow up

Trial details

NCT IDNCT01568879

SponsorKaiser Permanente

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-11

View on ClinicalTrials.gov More Recurrent or Tophaceous Gout trials